Ono Pharmaceutical Co., Ltd.
OPHLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5 | $725 | $739 | $772 |
| - Cash | $1 | $139 | $205 | $161 |
| + Debt | $1 | $138 | $147 | $154 |
| Enterprise Value | $5 | $724 | $681 | $765 |
| Revenue | $1 | $128 | $112 | $134 |
| % Growth | -99.3% | 13.6% | -16.3% | – |
| Gross Profit | $1 | $91 | $67 | $88 |
| % Margin | 73% | 71% | 59.7% | 65.9% |
| EBITDA | $0 | $31 | -$6 | $24 |
| % Margin | 30.9% | 24.5% | -5.2% | 17.9% |
| Net Income | $0 | $18 | -$7 | $15 |
| % Margin | 17.4% | 13.9% | -5.8% | 11.1% |
| EPS Diluted | 0.11 | 12.53 | -4.66 | 10.6 |
| % Growth | -99.1% | 368.9% | -144% | – |
| Operating Cash Flow | $0 | $3 | $39 | $0 |
| Capital Expenditures | -$0 | -$2 | -$1 | -$0 |
| Free Cash Flow | $0 | $1 | $38 | $0 |